Abris Capital buys Scanmed for PLN 340m

The GP invested in the company via Abris CEE Mid-Market III, which held a final close on its €500m target in September 2017. The fund focuses on majority ownership positions in mid-market privately owned businesses across the CEE region.

Previous investments made by the fund in the healthcare sector include ITP, a Polish specialist in aesthetic medicine products; and Dentotal Protect, a distributor of dental consumables and equipment in Romania.

Abris intends to support Scanmed in broadening its service offering and geographical presence, while improving its medical facilities and further expanding in key therapeutic areas. The company also plans to open new labs and surgery units, and increase its revenues in the orthopaedics, ophthalmology, rehabilitation and urogynaecology segments.

The vendor, Life Healthcare Group Holdings, is a South African listed company specialising in managing hospitals and medical clinics. The group intends to use the proceeds from the sale to reduce its debt levels, according to a statement.  

Company
Established in 2003, Scanmed operates a network of clinics based in 42 locations across Poland, offering a wide range of medical and diagnostics services in gynaecology and obstetrics, urogynaecology, aesthetic medicine and orthopaedics.

The company manages two multi-specialism hospitals, 13 cardiac centres offering comprehensive diagnostics and cardiological treatment, and a variety of clinics and medical centres. Scanmed also provides outpatient care services in several Polish cities, including Warsaw, Kraków, Poznan, Wroclaw, Gdansk and Pabianice.

The company reported EBITDA of PLN 34m from revenues of PLN 373m in the year to 30 September 2020.

People
Abris Capital Partners – Wojciech Łukawski (partner).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• CEE
• Healthcare
• Abris Capital Partners
• Poland